This HTML5 document contains 42 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n8http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q71127863
rdf:type
wikibase:Item
schema:description
im Mai 1996 veröffentlichter wissenschaftlicher Artikel scientific article published on 01 May 1996 наукова стаття, опублікована в травні 1996 wetenschappelijk artikel artículu científicu espublizáu en mayu de 1996
p:P577
wds:Q71127863-BE112D83-61FC-421A-9759-F49B54367D92
wdt:P577
1996-05-01T00:00:00Z
p:P407
wds:Q71127863-FF01CE1A-6852-459A-AAE3-ECA0CA967B83
wdt:P407
wd:Q1860
p:P2093
wds:Q71127863-2097C089-8FB1-4B74-80A5-B3FD146BDFDA wds:Q71127863-D82840CC-5A11-44C6-9F32-989978BC2B42 wds:Q71127863-4593C3E2-0303-4EF6-8384-05EA44763903
wdt:P2093
R S Thrall C L Swendsen V Skita
rdfs:label
Alterations in surfactant neutral lipid composition during the development of bleomycin-induced pulmonary fibrosis Alterations in surfactant neutral lipid composition during the development of bleomycin-induced pulmonary fibrosis
skos:prefLabel
Alterations in surfactant neutral lipid composition during the development of bleomycin-induced pulmonary fibrosis Alterations in surfactant neutral lipid composition during the development of bleomycin-induced pulmonary fibrosis
schema:name
Alterations in surfactant neutral lipid composition during the development of bleomycin-induced pulmonary fibrosis Alterations in surfactant neutral lipid composition during the development of bleomycin-induced pulmonary fibrosis
p:P1476
wds:Q71127863-4C130B2A-B041-49B8-BC7C-EF7A10265BCF
wdt:P1476
Alterations in surfactant neutral lipid composition during the development of bleomycin-induced pulmonary fibrosis
p:P304
wds:Q71127863-C8E5BF76-4B45-4BCB-80E3-7827D297C4EC
wdt:P304
90-96
p:P31
wds:Q71127863-2D73E579-CC4F-48D5-B564-ADBBCE85A506
wdt:P31
wd:Q13442814
p:P921
wds:Q71127863-FC1A6F66-7E82-43E0-B8A2-E7897F74677A
wdt:P921
wd:Q32446
p:P698
wds:Q71127863-01BBCB0E-83AF-4571-AB26-07268D15CBAD
wdtn:P698
n7:8652656
wdt:P698
8652656
p:P1433
wds:Q71127863-5A7D9656-73AA-4BD5-A558-469443B84BDD
wdt:P1433
wd:Q864239
p:P433
wds:Q71127863-0748E984-EA68-4DA0-976B-F0BEB10F0F98
p:P478
wds:Q71127863-278A1D48-6B2E-4F04-91FB-D9D59D8B6FAA
wdt:P433
1-2
wdt:P478
1301
p:P356
wds:Q71127863-4C4342A3-108B-4B73-853E-9E4E9500653F
wdtn:P356
n8:0005-2760(96)00023-9
wdt:P356
10.1016/0005-2760(96)00023-9